Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2012

Aug 29, 2012

30071_dirs_2012-08-29_43b02c6f-a1e8-46b4-947f-f05caf1695b2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-08-27

Reporting Person: WAREHAM JOHN P (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-08-27 ResMed Common Stock M 18000 $21.025 Acquired 31000 Direct
2012-08-27 ResMed Common Stock S 18000 $37.341 Disposed 13000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-08-27 ResMed NQ Stock Options $21.025 M 18000 Disposed 2014-11-07 ResMed Common Stock (18000) Direct

Footnotes

F1: There is a holding period until the earlier of 3 years from the date of grant or 6 months from the termination of directorship.